Search
Maravai LifeSciences Holdings Inc
MRVIAdd to Watchlist
6.570USD
-0.180-2.67%
Close 07-31 16:00（ET）Quotes delayed by 15 min
1.70BMarket Cap
LossP/E TTM
More Details of Maravai LifeSciences Holdings Inc Company
Maravai LifeSciences Holdings, Inc. is a life sciences company providing critical products to enable the development of drug therapies, diagnostics and novel vaccines and to support research on human diseases. Its segments include Nucleic Acid Production Segment and Biologics Safety Testing Segment. The Nucleic Acid Production segment is focused on the manufacturing and sale of highly modified nucleic acids products to support the needs of customers’ research, therapeutic and vaccine programs. This segment’s business units include TriLink Discovery, TriLink GMP, Glen Research and Alphazyme. The Biologics Safety Testing segment is focused on manufacturing and selling biologics safety and impurity tests and assay development services that are utilized by its customers in their biologic drug manufacturing activities. This segment’s business is comprised of Cygnus Technologies. It serves various companies, including biopharmaceutical, vaccine, diagnostics and cell and gene therapy.
Maravai LifeSciences Holdings Inc Info
Ticker SymbolMRVI
Company nameMaravai LifeSciences Holdings Inc
IPO dateNov 20, 2020
CEOBrust (Bernd)
Number of employees570
Security typeOrdinary Share
Fiscal year-endNov 20
Address10770 Wateridge Circle Suite 200
CitySAN DIEGO
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code92121
Phone18585460004
Websitehttps://www.maravai.com/
Ticker SymbolMRVI
IPO dateNov 20, 2020
CEOBrust (Bernd)
Company Executives of Maravai LifeSciences Holdings Inc
Name
Name/Position
Position
Shareholding
Change
Mr. Bernd Brust
Mr. Bernd Brust
Chief Executive Officer, Director
Chief Executive Officer, Director
1.62M
-1.81%
Ms. Christine Dolan
Ms. Christine Dolan
Executive Vice President, General Manager - Cygnus Technologies
Executive Vice President, General Manager - Cygnus Technologies
434.95K
+1.15%
Mr. Rajesh J. (Raj) Asarpota
Mr. Rajesh J. (Raj) Asarpota
Chief Financial Officer
Chief Financial Officer
434.42K
-15.10%
Mr. Robert Andrew (Andy) Eckert
Mr. Robert Andrew (Andy) Eckert
Independent Chairman of the Board
Independent Chairman of the Board
412.18K
+11.23%
Mr. Kurt Oreshack
Mr. Kurt Oreshack
Executive Vice President, General Counsel, Secretary
Executive Vice President, General Counsel, Secretary
267.40K
-18.70%
Mr. Gregory T. (Greg) Lucier
Mr. Gregory T. (Greg) Lucier
Independent Director
Independent Director
264.91K
-17.48%
Ms. Susannah Gray
Ms. Susannah Gray
Independent Director
Independent Director
216.20K
+21.41%
Mr. Luke Joseph Marker
Mr. Luke Joseph Marker
Director
Director
184.35K
+25.11%
Mr. Constantine S. (Dean) Mihas
Mr. Constantine S. (Dean) Mihas
Director
Director
--
--
Mr. Sean L. Cunningham
Mr. Sean L. Cunningham
Director
Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Bernd Brust
Mr. Bernd Brust
Chief Executive Officer, Director
Chief Executive Officer, Director
1.62M
-1.81%
Ms. Christine Dolan
Ms. Christine Dolan
Executive Vice President, General Manager - Cygnus Technologies
Executive Vice President, General Manager - Cygnus Technologies
434.95K
+1.15%
Mr. Rajesh J. (Raj) Asarpota
Mr. Rajesh J. (Raj) Asarpota
Chief Financial Officer
Chief Financial Officer
434.42K
-15.10%
Mr. Robert Andrew (Andy) Eckert
Mr. Robert Andrew (Andy) Eckert
Independent Chairman of the Board
Independent Chairman of the Board
412.18K
+11.23%
Mr. Kurt Oreshack
Mr. Kurt Oreshack
Executive Vice President, General Counsel, Secretary
Executive Vice President, General Counsel, Secretary
267.40K
-18.70%
Mr. Gregory T. (Greg) Lucier
Mr. Gregory T. (Greg) Lucier
Independent Director
Independent Director
264.91K
-17.48%
FAQs
Who are the top five shareholders of Maravai LifeSciences Holdings Inc?
The top five shareholders of Maravai LifeSciences Holdings Inc are: Mr. Bernd Brust
How many institutions hold shares of Maravai LifeSciences Holdings Inc (MRVI)?
As of 2026Q1, 476 institutions hold shares of Maravai LifeSciences Holdings Inc, with a combined market value of approximately 140.69M, accounting for 95.39% of the total shares. Compared to 2025Q4, institutional shareholding has increased by -29121507.00.